Head to head
SnagRx vs Novi: GLP-1 Programs Compared (2026)
SnagRx or Novi? Side-by-side 2026 pricing, medication and service comparison, extended to six and twelve-month totals.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.5 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
If SnagRx and Novi are the two tabs still open, the deciding information is not on either homepage — it is in what happens after the first month.
Where they diverge is the pitch: the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly at SnagRx, against the narrowest gap here between semaglutide and tirzepatide pricing, at $133 and $166 at Novi.
Below, the two programs are set against the things that change the bill — the advertised rate, the rate after the promotion expires, the medication class and the inclusions. No number here is inferred; if a provider does not publish it, the table says so.
The short answer
- Lowest 12-month cost
- SnagRx — $828 against $1,596 at Novi, on each provider's own best published pricing.
- Most predictable bill
- SnagRx — Flat rate at every dose, so titration does not change what you are charged.
- Fastest route to a first shipment
- SnagRx — 5-minute intake, clinician review typically within 5 hours and always within 24, then free next-day UPS or FedEx in temperature-controlled packaging.
- Easiest to pay for
- SnagRx — Neither publishes financing; both expect the full amount monthly.
SnagRx and Novi, side by side
This is the whole comparison in one screen. The sections underneath explain which of these rows should decide it.
| SnagRx | Novi | |
|---|---|---|
| Advertised price | Semaglutide $99/mo month-to-month, or $69/mo on the 12-month plan | Semaglutide from $133/mo, tirzepatide from $166/mo |
| Rate after promotions | $99/mo | $133/mo |
| Pricing structure | Flat rate at every dose | Published rate per medication |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide and compounded tirzepatide |
| Price transparency | Published upfront | Published upfront |
| Tirzepatide | $149/mo | $166/mo |
| Support model | No coaching program stated | No coaching program stated |
| Shipping | Free next-day UPS or FedEx in temperature-controlled packaging | Free 2-day shipping with every order |
| Patient reviews | 9,860 | 50,124 |
| eRxDoctor score | 7.5/10 | 7.0/10 |
SnagRx vs Novi on total cost, not entry price
The cheapest first month and the cheapest year are frequently different providers. These are the totals — six months and twelve — using each provider's own published rates and best available plan.
| SnagRx | Novi | |
|---|---|---|
| First month | $99 | $133 |
| Months 2 onward | $99/mo | $133/mo |
| 6-month total | $594 | $798 |
| 12-month total | $1,188 | $1,596 |
| Best published plan | 12-month semaglutide plan at $69/mo ($828 a year) — $828/yr | No multi-month discount published |
The twelve-month spread is $768. That is the number to hold Novi against: it has to justify roughly $64 extra every month.
The difference that actually decides it
SnagRx leads with the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly. Novi leads with the narrowest gap here between semaglutide and tirzepatide pricing, at $133 and $166. Both are true, and neither is the reason most people end up unhappy with a GLP-1 program.
The reasons they do are duller: a price that moved, a support queue that did not answer, or a medication that was not available at the dose they needed. On those, SnagRx is exposed on one thing (the advertised $69 and $119 rates require the 12-month plan — month-to-month is $99 and $149) and Novi on another (the $133 rate depends on a $200-off promotion and there is no outcome guarantee).
Read those two caveats again before the marketing. Choosing a provider is mostly choosing which compromise you are prepared to make.
A closer look at SnagRx
SnagRx offers compounded semaglutide from $69/month and tirzepatide from $119/month, with the rate locked flat at every dose, named US 503A pharmacies and next-day shipping. What it is really selling here is the rate is locked at every dose for the life of treatment, and the four US 503A partner pharmacies and the prescribing clinician network are both named publicly.
Getting started means 5-minute intake, clinician review typically within 5 hours and always within 24, after which free next-day UPS or FedEx in temperature-controlled packaging. Pricing runs on a flat rate at every dose basis, published upfront.
Ongoing care is 1:1 nursing staff plus a secure patient portal for refills and dose changes, and the medication list runs to compounded semaglutide and compounded tirzepatide.
SnagRx pros
- Bottom-of-market pricing on the annual plan: $69/mo semaglutide, $119/mo tirzepatide
- Price locked flat at every dose and at renewal — no re-pricing during titration
- Names its four US 503A partner pharmacies and its clinician network (OpenLoop Health)
- States LegitScript certification, which patients can verify independently
SnagRx cons
- Compounded medication only, no branded Ozempic, Wegovy, Mounjaro, or Zepbound
- The advertised $69 and $119 rates require the 12-month plan; month-to-month is $99 and $149
- Heavy urgency marketing, including a countdown timer on the pricing page
The reservation worth holding, particularly next to Novi: the advertised $69 and $119 rates require the 12-month plan — month-to-month is $99 and $149.
Inside the Novi program
$200 OFF - GLP-1 for $133 Today In this pairing, its distinguishing feature is the narrowest gap here between semaglutide and tirzepatide pricing, at $133 and $166.
Intake is online intake. Fulfillment is free 2-day shipping with every order. The commercial terms are published rate per medication, published upfront.
Support: no long-term contract, cancel anytime. The medications on offer are compounded semaglutide and compounded tirzepatide.
Novi pros
- $200 off promotion brings GLP-1 to $133 today
- No insurance required and no long-term contract, cancel anytime
- Competitive pricing: semaglutide from $133/month and tirzepatide from $166/month
- Largest patient base on this list, 50,000+ patients, signaling operational maturity
Novi cons
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Tirzepatide ($166) costs more than the semaglutide entry rate
- No published outcome or weight loss guarantee
Read next to SnagRx, the weak point: the $133 rate depends on a $200-off promotion and there is no outcome guarantee.
Who each program is actually built for
Choose SnagRx if:
- the twelve-month total is what you are optimizing ($1,188 against $1,596)
- you are willing to commit for a term in exchange for a lower effective rate (12-month semaglutide plan at $69/mo ($828 a year))
- you want the price you sign up at to survive titration
- the monthly rate is the constraint — $99/mo against $133/mo
Choose Novi if:
- delivery works the way you want it to: free 2-day shipping with every order
- you would rather use the platform with the longer public record (50,124 reviews)
- the feature you would actually use: the narrowest gap here between semaglutide and tirzepatide pricing, at $133 and $166
- the level of clinical contact suits you: no long-term contract, cancel anytime
The compromises on both sides
On price. The monthly gap is 34% in SnagRx's favor. Whether that is a saving or a false economy turns on one thing: the advertised $69 and $119 rates require the 12-month plan — month-to-month is $99 and $149.
On predictability. Flat rate at every dose at SnagRx, against published rate per medication at Novi. The more predictable structure is worth a premium to anyone who has been surprised by a telehealth invoice before.
On commitment. SnagRx rewards a longer commitment (12-month semaglutide plan at $69/mo ($828 a year)), which lowers the effective rate but ties up money before you know how you respond to the medication. Neither publishes financing options, so plan for the full amount each month.
On clinical contact. SnagRx provides 1:1 nursing staff plus a secure patient portal for refills and dose changes. Novi provides no long-term contract, cancel anytime. Both are asynchronous-first services and neither replaces a physician who can examine you.
The medication, not the platform
Neither SnagRx nor Novi manufactures the molecule it prescribes, and the clinical evidence behind GLP-1 treatment belongs to the drug rather than to any platform selling access to it.
The NIH position is that weight-management medication works alongside changes in eating and activity, not instead of them, per NIH, NIDDK.
In SURMOUNT-1, tirzepatide reached a mean body-weight reduction of about 21% at the 15 mg dose over 72 weeks, per NEJM, SURMOUNT-1.
Neither platform's marketing changes any of that. It is the same evidence base whichever one takes your card.
SnagRx vs Novi: common questions
Is SnagRx cheaper than Novi?
Yes, on the ongoing rate. SnagRx runs $99/mo once promotional pricing ends, against $133/mo at Novi — a difference of 34%. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
Which has more patient reviews, SnagRx or Novi?
Novi, with 50,124 against 9,860. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
How fast can I start with SnagRx compared with Novi?
SnagRx advertises 5-minute intake, clinician review typically within 5 hours and always within 24, with free next-day UPS or FedEx in temperature-controlled packaging. Novi advertises online intake, with free 2-day shipping with every order. Both are subject to clinician review and to whether your state and health history clear, so treat the advertised timeline as a best case rather than a commitment.
Do SnagRx or Novi take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
Do SnagRx and Novi prescribe the same medication?
Both dispense compounded GLP-1 preparations. SnagRx lists compounded semaglutide and compounded tirzepatide and Novi lists compounded semaglutide and compounded tirzepatide, so the molecules overlap even where the formulary does not match exactly.
Can I switch from SnagRx to Novi later?
You can, and people do — usually when an introductory price expires. Budget for a repeat intake and a short overlap in supply, and confirm what happens to any unused portion of a multi-month plan before you cancel it.
The verdict
Strictly on cost, SnagRx takes it — $828 to $1,596 over twelve months.
Where Novi justifies itself is the narrowest gap here between semaglutide and tirzepatide pricing, at $133 and $166. Where it does not is anywhere the extra spend buys features you will never open.
The failure mode here is not picking the wrong platform; it is stopping treatment because the bill moved. Choose the one whose bill you can predict.
Keep comparing
- TrimRx vs SnagRxBudget vs premium
- Measured vs SnagRxCoaching-supported vs medication-only
- Novi vs Mochi HealthTirzepatide access
- Novi vs IVIM HealthTirzepatide access
- LIV Body vs TMatesHead to head
- Refills vs Elevate HealthHead to head
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by SnagRx or Novi, and does not sell treatment. Read our ranking methodology.